Ticlid seems to increase the risk of another potentially fatal blood disorder

Ticlid seems to increase the risk of another potentially fatalblood disorder...thrombotic thrombocytopenic purpura (TTP).

Ticlid patients are already being monitored for neutropenia...now there are at least 60 reports of TTP.

TTP leads to thrombocytopenia...anemia...renal dysfunction...and neurologic changes that can be confused with a stroke. About 30%of these patients die.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote